Linear interaction energy: method and applications in drug design.
Hugo Gutiérrez-de-Terán1, Johan Aqvist
1Fundación Pública Galega de Medicina Xenómica, Santiago University Hospital, Santiago de Compostela, Spain. hugo.teran@usc.es
Methods in Molecular Biology (Clifton, N.J.)
|December 21, 2011
Summary
This guide explains the linear interaction energy (LIE) method for calculating ligand-protein binding affinities. It combines molecular dynamics (MD) sampling with analysis for accurate drug design predictions.
Area of Science:
- Computational chemistry
- Molecular modeling
- Drug discovery
Background:
- Estimating ligand-protein binding affinities is crucial for drug design.
- Various computational methods are available, each with strengths and limitations.
Purpose of the Study:
- To provide a comprehensive guide to the linear interaction energy (LIE) method.
- To detail its application in drug design for binding free energy calculations.
Main Methods:
- Utilizes the linear interaction energy (LIE) method.
- Integrates molecular dynamics (MD) sampling for conformational analysis.
- Includes procedures for analyzing MD sampling to ensure accuracy.
Main Results:
- Demonstrates the LIE method's utility in estimating binding free energies.
- Provides insights into optimizing MD sampling for reliable results.
- Highlights key considerations for accurate affinity estimations.
Conclusions:
- The LIE method, combined with MD sampling, offers a robust approach for binding free energy calculations.
- Proper analysis of sampling is essential for achieving accurate ligand-binding affinity predictions in drug design.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:16Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...